1. Home
  2. XOMA vs SPOK Comparison

XOMA vs SPOK Comparison

Compare XOMA & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • SPOK
  • Stock Information
  • Founded
  • XOMA N/A
  • SPOK 2004
  • Country
  • XOMA United States
  • SPOK United States
  • Employees
  • XOMA N/A
  • SPOK N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • SPOK Telecommunications Equipment
  • Sector
  • XOMA Health Care
  • SPOK Telecommunications
  • Exchange
  • XOMA Nasdaq
  • SPOK Nasdaq
  • Market Cap
  • XOMA 298.3M
  • SPOK 333.4M
  • IPO Year
  • XOMA N/A
  • SPOK 1992
  • Fundamental
  • Price
  • XOMA $28.06
  • SPOK $16.08
  • Analyst Decision
  • XOMA Strong Buy
  • SPOK
  • Analyst Count
  • XOMA 2
  • SPOK 0
  • Target Price
  • XOMA $57.00
  • SPOK N/A
  • AVG Volume (30 Days)
  • XOMA 33.8K
  • SPOK 110.0K
  • Earning Date
  • XOMA 08-06-2024
  • SPOK 07-24-2024
  • Dividend Yield
  • XOMA N/A
  • SPOK 7.77%
  • EPS Growth
  • XOMA N/A
  • SPOK N/A
  • EPS
  • XOMA N/A
  • SPOK 0.82
  • Revenue
  • XOMA $5,811,000.00
  • SPOK $140,753,000.00
  • Revenue This Year
  • XOMA $349.94
  • SPOK $2.77
  • Revenue Next Year
  • XOMA $28.50
  • SPOK $0.94
  • P/E Ratio
  • XOMA N/A
  • SPOK $19.61
  • Revenue Growth
  • XOMA 73.10
  • SPOK 5.13
  • 52 Week Low
  • XOMA $13.48
  • SPOK $10.90
  • 52 Week High
  • XOMA $29.00
  • SPOK $18.14
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 60.03
  • SPOK 63.81
  • Support Level
  • XOMA $25.46
  • SPOK $16.03
  • Resistance Level
  • XOMA $27.05
  • SPOK $16.66
  • Average True Range (ATR)
  • XOMA 1.35
  • SPOK 0.36
  • MACD
  • XOMA 0.34
  • SPOK 0.13
  • Stochastic Oscillator
  • XOMA 83.77
  • SPOK 70.10

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise. The company provides paging services and software solutions in the United States and abroad. It provides services such as Value-Added Services, Advisory Services, Assessment Services and Adoption Services.

Share on Social Networks: